Registration

Gel-based Microarrays in Clinical Diagnostics and Oncology
Dimitry Gryadunov, Postdoctoral Fellow, Engelhardt Institute of Molecular Biology, Russian Federation

A technology of three-dimensional hydrogel microarrays (biochips) has been developed, patented, and implemented for practical medical diagnostics. The biochips allow timely detection of socially dangerous diseases, as cancer, cardiovascular illnesses, hereditary diseases and different infections.

Rapid Clinical Diagnostics in a Continuous Flow Lab on a Chip
Nicole Pamme, Professor in Analytical Chemistry, Stockholm University, Sweden

We present a fast, highly versatile microfluidic platform which utilises mobile magnetic particles for performing surface-based assays in continuous flow within a fraction of the time required for conventional methods.

Coffee and Networking in Exhibition Hall

The (Semi-) Blockbuster Diagnostic
Steven Bodovitz, Principal, Bioperspectives, United States of America

The new era of molecular diagnostics requires a new era of business models.

Novel Classes of Biomarkers for Personalized Medicine: Epigenetics and microRNA
Enal Razvi, Managing Director, Select Biosciences Inc, United States of America

This presentation describes the market analysis of two emerging classes of biomarkers: Epigenetics-based and microRNA based. These biomarkers have demonstrated value in cancer personalized medicine and the challenge now is to broaden their utility to various other disease classes. In this talk, I describe our most-recent bottom-up primary market data that characterizes these biomarkers and their opportunity they present.

Lunch and Networking in Exhibition Hall

Poster Viewing

RAP-ID – A New Device for Rapid Molecular Diagnostics of Ventilator-associated Pneumonia
Jan Weile, Project Leader, Institute for Laboratory and Transfusion Medicine at the Heart and Diabetes Centre, Germany

Results comparison of RAP-ID, a novel hybrid technology for pathogen and antibiotic resistance testing, combining multiplex amplification and real-time detection on microarray, with conventional microbiology and PCR methods.

Sample In - Answer Out: Integrated Microfluidic Cartridges for Cancer and POC Molecular Diagnostics
Holger Becker, Chief Scientific Officer, Microfluidic ChipShop GmbH, Germany

Microfluidics is an enabling technology which allows the development of highly integrated molecular diagnostic devices, ultimately integrating all diagnostic steps from sample input to a diagnostic answer on a single device. We will present several examples of such developments which include steps like sample preparation, amplification and detection on-chip.

Coffee and Networking in Exhibition Hall

Luminescent Nanoparticles in Medical Diagnostics
Joern Probst, Head, Frauenhofer Institute, Germany

In this presentation we will discuss the multifunctional luminescent nanoparticles tailored for in vitro and in vivo diagnostics which are part of an innovative particle concept developed by Fraunhofer ISC. This concept also includes drug release options to open up the pathway to theranostics.

Selector Technology - A Powerful Approach for Clinical Re-Sequencing
Fredrik Dahl, Chief Technical Officer, Halo Genomics, Sweden

Targeted DNA re-sequencing using the high-performing Selector Technology enables a powerful approach to analyze clinical samples in a cost-effective and high-throughput fashion.

Close of Day One

Peptide-nucleic Acids (PNAs) in SPR-based Molecular Diagnosis of Human Genetic Diseases
Roberto Gambari, Professor, University of Ferrara, Italy

Novel Instrumentation Complex for Molecular Diagnostics and Personalized Medicine
Vera Gorfinkel, Professor, State University of New York/Genometrica Ltd, United States of America

A novel instrumentation complex GenometricaLab employs a single photon spectrometer and performs a variety of molecular-diagnostic tests based on ultra fast and highly accurate single photon detection of multi-color fluorescence from labeled objects (DNA molecules, color beads, quantum dots, etc.).

Proximity Probing Assays for Multiplexed Panel Diagnostics of Serum Samples and Protein Interaction Based
Simon Fredriksson, CEO, Olink, Sweden

By converting protein biomarkers into ID-coded PCR amplicons, the proximity probing assays enables rapid.

Coffee and Networking in Exhibition Hall

Ice COLD-PCR and BLOCker Sequencing for Very High Sensitivity Somatic Mutation Detection
Philip Eastlake, Research and Development, Transgenomic, United States of America

Transgenomic has developed very high sensitivity somatic mutation detection methods. Results will be shown for Ice-COLD PCR and BLOCker sequencing in samples such as low tumor-load biopsies, FFPEs, FNAs, CTCs and cfDNA in tumor-matched plasma and serum.

Assays and Diagnostics of Biothreat Toxins – Addressing the Challenge of Sensitive Rapid Identification and Biological Activity
Bal Singh, Professor, University of Massachusetts Dartmouth, United States of America

This presentation will highlight challenges involved in sample processing, rapid detection, sensitivity, and biological activity of toxins which pose threat of intentional exposure. A combination of instrumentation, chemistry, and biology is being employed to meet these challenges.

Lunch and Networking in Exhibition Hall

Poster Viewing

Novel Bioinformatics Approach in Disease Related Biomarker Discovery
Elena Schwartz, CSO, Ariadne Diagnostics LLC, United States of America

We are going to present a novel bioinformatics approach in Ariadne has developed a literature-derived database of disease-associated protein biomarkers. We used this new bioinformatics method to propose hormone related cancer pathways from an analysis of literature and omics datasets.

Close of Conference